Miriam Arago Galindo
Overview
Explore the profile of Miriam Arago Galindo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A, Galindo M, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Apr;
35:100433.
PMID: 38617837
Background: World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised regimens for eligible patients with pulmonary drug-resistant tuberculosis (DR-TB); however, data for patients with drug-resistant extrapulmonary tuberculosis (EPTB)...
2.
Gill N, Van den Bergh R, Kyaw K, Laxmeshwar C, Das M, Rastogi S, et al.
PLoS One
. 2019 Nov;
14(11):e0225631.
PMID: 31751433
Background: HIV programs are increasingly confronted with failing antiretroviral therapy (ART), including second-line regimens. WHO has provided guidelines on switching to third-line ART. In a Médecins Sans Frontières clinic in...
3.
Bastard M, Molfino L, Mutaquiha C, Galindo M, Zindoga P, Vaz D, et al.
Clin Infect Dis
. 2019 Mar;
69(10):1809-1811.
PMID: 30901021
Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB...